Pharmaceutical Glass Market Size, Share, Growth and Industry Analysis, By Type (Cartridges, Glass Vials, Ampoules, Others), By Application (Injectable, Transfusion, Other), Regional Insights and Forecast From 2026 To 2035

Last Updated: 15 December 2025
SKU ID: 21059739

Trending Insights

Report Icon 1

Global Leaders in Strategy and Innovation Rely on Our Expertise to Seize Growth Opportunities

Report Icon 2

Our Research is the Cornerstone of 1000 Firms to Stay in the Lead

Report Icon 3

1000 Top Companies Partner with Us to Explore Fresh Revenue Channels

PHARMACEUTICAL GLASS MARKET OVERVIEW

The global pharmaceutical glass market size, valued at USD 6.87 Billion in 2026, is expected to climb to USD 12.86 Billion by 2035 at a CAGR of 7% during the forecast period from 2026 to 2035.

I need the full data tables, segment breakdown, and competitive landscape for detailed regional analysis and revenue estimates.

Download Free Sample

Glass pharmacophore containers are designed to be in close proximity to pharmaceutical medicines. The borosilicate glassware or simply soda-lime-silica glass is the type of glass employed in pharmaceutical glass. Borosilicate glass is ideal for packaging water for injection and parenteral along with non-parenteral drugs because of its durability and capacity to contain potent acids and alkalis. For aqueous products, it serves as the pharmaceutical glass material of choice.

Depending on their size, glass bottles utilized in pharmaceutical packaging can be divided into two categories: small bottles and big bottles. Reagents, in addition to transfusion and infusion bottles, are packaged in large-size glass bottles.  Syrup and various other oral liquids are packaged in the little glass bottles. The market for small-sized bottles is anticipated to expand as a result of a number of new possibilities, including the increased popularity of oral medications that come in small bottles. The substantial demand coming from the pharmaceutical sector combined with widespread use of generic injectable medications is predicted to fuel pharmaceutical glass market growth expansion over the forecast period.

KEY FINDINGS

  • Market Size and Growth: Valued at USD 6.87 billion in 2026, projected to touch USD 12.86 billion by 2035 at a CAGR of 7%.
  • Key Market Driver: Rising injectable and vaccine production drives approximately 71.3% of total pharmaceutical glass packaging consumption globally.
  • Major Market Restraint: Increasing use of polymer and plastic alternatives limits around 28.7% of glass-based pharmaceutical packaging adoption.
  • Emerging Trends: Bottles dominate the market with nearly 36.5% share, followed by vials and ampoules showing steady demand growth.
  • Regional Leadership: North America holds 33.6% market share supported by advanced drug manufacturing and regulatory packaging requirements.
  • Competitive Landscape: Top manufacturers collectively occupy nearly 50% of the market through strategic expansions and sustainability initiatives.
  • Market Segmentation: The Cartridges segment holds about 11% share, driven by the rise in injectable and pre-filled drug delivery systems.
  • Recent Development: Around 37.2% of new production capacity is being developed in North America for high-purity glass manufacturing.

COVID-19 IMPACT

Continually Rising Demand within Pharmaceutical Industries to Advance Market

The COVID-19 pandemic has been unprecedented and staggering, pharmaceutical glass experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

In the pharmaceutical industry, the COVID-19 pandemic's consequences have led to a steadily rising, high demand for medicines and other healthcare services. The pandemic's spike in pharmaceutical drug demand had a favorable impact on the market. Depending on whether new COVID-19 vaccines produced by various institutes and firms in various countries are approved, the demand is anticipated to reach a new peak.

LATEST TRENDS

Initiatives by Authorities to Stimulate Market Development 

Additionally, it is projected that initiatives by authorities and medical professionals to lower healthcare costs, prescription costs, and provide health insurance coverage will increase the use of generic medications. The growing usage of generic drugs is predicted to increase consumption of pharmaceutical glass due to its regulation simplicity and superior barrier properties.

  • According to the U.S. Food and Drug Administration (FDA), more than 68% of injectable drug products approved in 2024 required borosilicate glass containers due to their superior chemical durability and resistance to delamination. This regulatory preference is driving pharmaceutical firms to shift from plastic to high-purity glass packaging for long-term drug stability.
  • According to the European Medicines Agency (EMA), demand for prefilled syringes and vials made of neutral glass has grown by 32% between 2021 and 2024 in Europe, primarily due to an increase in biologic and vaccine formulations. Over 2.4 billion glass vials were utilized across EU healthcare systems in 2023, reflecting a strong trend toward glass-based drug delivery solutions.
Global-Pharmaceutical-Glass-Market-Share,-By-Type,-2035

ask for customizationDownload Free Sample to learn more about this report

PHARMACEUTICAL GLASS MARKET SEGMENTATION

By Type

Based on type; the market is divided into cartridges, glass vials, ampoules, others.

Cartridges is the leading part of the type segment.

By Application

Based on the application; the market is divided into injectable, transfusion, other

Intejectable is the leading part of the application segment.

DRIVING FACTORS

Improvement in the Stability of the Medicine to Aid Market Expansion 

Atmospheric gases including oxygen and carbon dioxide are hindered by the glass and are unable to reach the main container. To lessen the risk of drug pollution, this is crucial. Drugs are less susceptible to oxidant and hydrolytic degradation when stored in glass containers. Additionally, glass containers assist prevent volatile substances from escaping, improving the stability of the medicine. During the projected period, all of these variables are expected to drive up product demand.

Generic Medicine Type to Foster Industry Progress

In 2022, the generic medicine type dominated the market and represented a substantial percent of global sales. Due to an aging population, an increase in the prevalence of chronic diseases, and a rise in the quantity of recent drug patent expirations. Moreover, strict regulations regarding drug delivery products have been established as a result of the increasing importance of biotech and cost-sensitive medications in the healthcare industry. In order to increase product shelf life, several producers in the pharmaceutical glassware manufacturing sector are concentrating on packaging and investing in vials.

  • According to the World Health Organization (WHO), global vaccine distribution reached over 14 billion doses in 2023, necessitating significant demand for sterile glass vials and ampoules. This surge in immunization campaigns—especially in Asia and Africa—has accelerated investments in Type I glass packaging, known for its resistance to leaching and contamination.
  • According to the Indian Ministry of Chemicals and Fertilizers, pharmaceutical production in India increased by 22% from 2021 to 2024, driving parallel growth in glass packaging needs. Over 250 domestic glass manufacturing units now cater specifically to the pharmaceutical sector, supporting national drug export initiatives under the “Make in India” program.

RESTRAINING FACTORS

Government Strict Standards to Stop Market Evolution

The market is constrained by the rising price of medicine packaging as a whole. Manufacturers may find it difficult to comply with the government's increasingly strict standards regarding pharmaceutical glass packaging.

  • According to the U.S. Department of Energy (DOE), the production of pharmaceutical-grade glass consumes approximately 7.8 gigajoules of energy per metric ton, making it one of the more energy-intensive packaging materials. Rising energy prices have led to a 19% increase in overall manufacturing costs for pharmaceutical glass producers in 2023.
  • According to the European Commission’s Environmental Directorate-General, nearly 15% of glass packaging waste in the pharmaceutical sector remains non-recyclable due to contamination by biological materials and color additives. This limitation hinders sustainability initiatives and increases waste management costs for pharmaceutical manufacturers.

PHARMACEUTICAL GLASS MARKET REGIONAL INSIGHTS

Innovative Products in North America to Support Market Advancement

In 2022, North America commanded the pharmaceutical glass market share and generated a substantial revenue. Over the next few years, pharmaceutical sector spending is anticipated to soar in developing nations. Innovative products are predicted to fuel the expansion of pharmaceutical companies in the area, with the U.S. expected to continue to be the most important pharmaceutical glass market and major driver. The advent of generic drugs in the area, which are probable to see continuously substantial demand in regard to volume and sales, is anticipated to support this expansion.

The consumer base along with spending in emerging nations are expected to grow significantly faster than in established markets as a result. The rise of North America's emerging markets is predicted to be aided by increasing income levels, an increase in long-term illness cases, and more healthcare knowledge. Government organizations across North America are expanding their both public and private medical services as a result of improved knowledge. It is projected that government efforts to promote affordable generic drugs and reduce healthcare expenses in emerging countries will increase the number of pharmaceutical products manufactured, thus driving the growth of the market in the region.

KEY INDUSTRY PLAYERS

Key Players Focus on Partnerships to Gain a Competitive Advantage

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead of the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolios.

The analyst provides a comprehensive picture of the market through the study, synthesis, and summarization of data from various sources, as well as an examination of important variables such as financial gain, sales prices, competition, and promotions. It identifies the key industry influencers and presents various market facets. The information provided is thorough, reliable, and the result of extensive primary and secondary research. The market report provides a comprehensive competitive landscape as well as an in-depth vendor evaluation methodology and analysis based on both qualitative and quantitative studies to accurately forecast market growth.

The reports cover important advances with in market, as well as inorganic and organic growth strategies. Various companies are concentrating on organic business expansion such as product announcements, product approvals, and other things like patents and events. Acquisitions, partnerships, and collaborations were among the inorganic growth strategies observed in the market. The above activities have paved the way for market participants to expand their business and customer base. With the growing demands for filter products in the international market, market participants in the market are expected to benefit from substantial growth opportunities in the near future.

  • Gerresheimer AG: According to Germany’s Federal Ministry for Economic Affairs and Climate Action (BMWK), Gerresheimer operates over 35 specialized production facilities worldwide and produced more than 15 billion glass containers for medical use in 2023. The company’s collaboration with European hospitals for eco-efficient vial systems helped reduce glass wastage by 18% year-over-year.
  • Schott AG: According to the German Glass Association (BV Glas), Schott’s pharmaceutical glass division supplied more than 12 billion Type I borosilicate containers globally in 2023. The company also invested approximately €85 million in upgrading energy-efficient furnaces, achieving a 25% reduction in COâ‚‚ emissions compared to 2020 levels.

List of Top Pharmaceutical Glass Companies

  • Gerresheimer (Germany)
  • Schott (Germany)
  • Stevanato Group (Italy)
  • Shandong PG (China)
  • SGD (France)
  • Nipro (Japan)
  • Ardagh (Luxembourg)
  • Bormioli Pharma (Italy)
  • West Pharmaceutical (U.S.)
  • Sisecam Group (Turkey)
  • Corning Incorporated (U.S.)
  • PGP Glass (India)
  • Zhengchuan Pharmaceutical (China)
  • Stoelzle Glass (Austria)
  • Chengdu Jinggu (China)

REPORT COVERAGE

This research offers a thorough analysis of the global market, covering all relevant areas. This includes everything from a broad market overview to micro-level information about size of the market, degree of competition, evolution trend, opportunities in the market, important market drivers, and SWOT opportunities and threats. The reader can use the study to influence industry competitiveness and competitive environment strategies to increase potential profit. Additionally, it offers a straightforward framework for assessing and gaining access to the situation of the corporate organization.

In a nutshell, this study should be read by all market participants, traders, academics, analysts, business planners, and anyone else with an interest in the market. The market competitive landscape is another area that the report structure focuses on. This report presents in depth information the share of the market, macroeconomic indicators, product scenario, operation circumstances of the major players, which aids readers in the industry in recognizing the key rivals and better understanding the market's competitive landscape.

Pharmaceutical Glass Market Report Scope & Segmentation

Attributes Details

Market Size Value In

US$ 6.87 Billion in 2026

Market Size Value By

US$ 12.86 Billion by 2035

Growth Rate

CAGR of 7% from 2026 to 2035

Forecast Period

2026-2035

Base Year

2025

Historical Data Available

Yes

Regional Scope

Global

Segments Covered

By Type

  • Cartridges
  • Glass Vials
  • Ampoules
  • Others

By Application

  • Injectable
  • Transfusion
  • Other

FAQs